🚀 VC round data is live in beta, check it out!

Lifecare Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lifecare and similar public comparables like Arcoma, Scandinavian Medical, Scandinavian Real Heart, Trinity Biotech and more.

Lifecare Overview

About Lifecare

Lifecare ASA focuses on the research, development, and commercialization of sensor technology for continuous monitoring of body analytes. Lifecare develops and licenses nanotechnology for medical use to facilitate the production and sale of medical devices. Its miniaturized sensor technology measures changes by reading osmotic pressure variations in a small chamber, and can, e.g., measure glucose and lactate levels by applying different chemical compositions. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.


Founded

2006

HQ

Norway

Employees

39

Financials (LTM)

Revenue: $159K
EBITDA: ($11M)

EV

$23M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lifecare Financials

Lifecare reported last 12-month revenue of $159K and negative EBITDA of ($11M).

In the same LTM period, Lifecare generated $96K in gross profit, ($11M) in EBITDA losses, and had net loss of ($11M).

Revenue (LTM)


Lifecare P&L

In the most recent fiscal year, Lifecare reported revenue of $12K and EBITDA of ($12M).

Lifecare expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Lifecare forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$159KXXX$12KXXXXXXXXX
Gross Profit$96KXXX—XXXXXXXXX
Gross Margin60%XXX—XXXXXXXXX
EBITDA($11M)XXX($12M)XXXXXXXXX
EBITDA Margin(6923%)XXX(98426%)XXXXXXXXX
EBIT Margin(7445%)XXX(112550%)XXXXXXXXX
Net Profit($11M)XXX($12M)XXXXXXXXX
Net Margin(6993%)XXX(103959%)XXXXXXXXX
Net Debt——$5MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Lifecare Stock Performance

Lifecare has current market cap of $13M, and enterprise value of $23M.

Market Cap Evolution


Lifecare's stock price is $0.04.

See Lifecare trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$23M$13M-0.1%XXXXXXXXX$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lifecare Valuation Multiples

Lifecare trades at 145.6x EV/Revenue multiple, and (2.1x) EV/EBITDA.

See valuation multiples for Lifecare and 15K+ public comps

EV / Revenue (LTM)


Lifecare Financial Valuation Multiples

As of April 20, 2026, Lifecare has market cap of $13M and EV of $23M.

Equity research analysts estimate Lifecare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Lifecare has a P/E ratio of (1.2x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$13MXXX$13MXXXXXXXXX
EV (current)$23MXXX$23MXXXXXXXXX
EV/Revenue145.6xXXX1940.4xXXXXXXXXX
EV/EBITDA(2.1x)XXX(2.0x)XXXXXXXXX
EV/EBIT(2.0x)XXX(1.7x)XXXXXXXXX
EV/Gross Profit242.7xXXX—XXXXXXXXX
P/E(1.2x)XXX(1.1x)XXXXXXXXX
EV/FCF(2.1x)XXX(1.9x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lifecare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lifecare Margins & Growth Rates

Lifecare's revenue in the last 12 month grew by 335%.

Lifecare's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.

Lifecare's rule of 40 is 3001% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lifecare's rule of X is 9543% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Lifecare and other 15K+ public comps

Lifecare Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth335%XXX4361%XXXXXXXXX
EBITDA Margin(6923%)XXX(98426%)XXXXXXXXX
EBITDA Growth(35%)XXX(38%)XXXXXXXXX
Rule of 40—XXX3001%XXXXXXXXX
Bessemer Rule of X—XXX9543%XXXXXXXXX
Revenue per Employee—XXX$0.0MXXXXXXXXX
Opex per Employee—XXX$0.4MXXXXXXXXX
G&A Expenses to Revenue—XXX13898%XXXXXXXXX
R&D Expenses to Revenue—XXX60664%XXXXXXXXX
Opex to Revenue—XXX116136%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Lifecare Public Comps

See public comps and valuation multiples for other Medical Devices comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
LifecareXXXXXXXXXXXXXXXXXX
ArcomaXXXXXXXXXXXXXXXXXX
Scandinavian MedicalXXXXXXXXXXXXXXXXXX
Scandinavian Real HeartXXXXXXXXXXXXXXXXXX
Trinity BiotechXXXXXXXXXXXXXXXXXX
Bionano GenomicsXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Lifecare M&A Activity

Lifecare acquired XXX companies to date.

Last acquisition by Lifecare was on XXXXXXXX, XXXXX. Lifecare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Lifecare

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Lifecare Investment Activity

Lifecare invested in XXX companies to date.

Lifecare made its latest investment on XXXXXXXX, XXXXX. Lifecare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Lifecare

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lifecare

When was Lifecare founded?Lifecare was founded in 2006.
Where is Lifecare headquartered?Lifecare is headquartered in Norway.
How many employees does Lifecare have?As of today, Lifecare has over 39 employees.
Is Lifecare publicly listed?Yes, Lifecare is a public company listed on Oslo Børs.
What is the stock symbol of Lifecare?Lifecare trades under LIFE ticker.
When did Lifecare go public?Lifecare went public in 2018.
Who are competitors of Lifecare?Lifecare main competitors are Arcoma, Scandinavian Medical, Scandinavian Real Heart, Trinity Biotech.
What is the current market cap of Lifecare?Lifecare's current market cap is $13M.
What is the current revenue of Lifecare?Lifecare's last 12 months revenue is $159K.
What is the current revenue growth of Lifecare?Lifecare revenue growth (NTM/LTM) is 335%.
What is the current EV/Revenue multiple of Lifecare?Current revenue multiple of Lifecare is 145.6x.
Is Lifecare profitable?No, Lifecare is not profitable.
What is the current EBITDA of Lifecare?Lifecare has negative EBITDA and is not profitable.
What is Lifecare's EBITDA margin?Lifecare's last 12 months EBITDA margin is (6923%).
What is the current EV/EBITDA multiple of Lifecare?Current EBITDA multiple of Lifecare is (2.1x).
What is the current FCF of Lifecare?Lifecare's last 12 months FCF is ($11M).
What is Lifecare's FCF margin?Lifecare's last 12 months FCF margin is (6948%).
What is the current EV/FCF multiple of Lifecare?Current FCF multiple of Lifecare is (2.1x).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial